Elias P. Pintus
Guy's And St Thomas' NHS Foundation Trust, Great Maze Pond
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study.
Journal: Nature cancer
Published: July 18, 2025
Artificial intelligence-driven streamlining of prostate cancer multidisciplinary team recommendations in a tertiary NHS centre in the UK.
Journal: BJU international
Published: July 01, 2025
Epicardial Metastases Causing Coronary Artery Compression and Myocardial Infarction on [ 18 F]FDG PET-CT.
Journal: Clinical nuclear medicine
Published: November 29, 2024
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards.
Journal: Nature reviews. Urology
Published: September 10, 2024
A cohort profile of the Graham Roberts study cohort.
Journal: Frontiers in oncology
Published: November 06, 2023
Rucaparib or Physician's Choice in Metastatic Prostate Cancer.
Journal: The New England journal of medicine
Published: February 16, 2023
Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study.
Journal: European urology
Published: December 09, 2022
Safe provision of systemic anti-cancer treatment for urological cancer patients during COVID-19: a tertiary centre experience in the first wave of COVID-19.
Journal: BMC urology
Published: November 20, 2021
The presenting dental status of solid tumours with bone metastases requiring bone-targeting agents - part 3: prostate cancer.
Journal: British dental journal
Published: December 14, 2020
Treatment Outcomes for Small Cell Carcinoma of the Bladder: Results From a UK Patient Retrospective Cohort Study.
Journal: International journal of radiation oncology, biology, physics
Published: November 24, 2020
Polyclonal BRCA2 mutations following carboplatin treatment confer resistance to the PARP inhibitor rucaparib in a patient with mCRPC: a case report.
Journal: BMC cancer
Published: June 24, 2019
Last Updated: 09/26/2026